INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626 | -38.3% | 12 | -25.0% | 0.00% | – |
| Q2 2023 | $1,014 | +17.0% | 16 | 0.0% | 0.00% | – |
| Q1 2023 | $867 | +82.1% | 16 | +77.8% | 0.00% | – |
| Q4 2022 | $476 | -88.1% | 9 | -89.0% | 0.00% | -100.0% |
| Q3 2022 | $4,000 | -33.3% | 82 | -26.8% | 0.00% | 0.0% |
| Q2 2022 | $6,000 | +500.0% | 112 | +1144.4% | 0.00% | – |
| Q1 2022 | $1,000 | – | 9 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 9 | +125.0% | 0.00% | – |
| Q3 2021 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 4 | -78.9% | 0.00% | – |
| Q1 2021 | $1,000 | – | 19 | +137.5% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 8 | -61.9% | 0.00% | – |
| Q2 2020 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 175,000 | $9,115,750 | 10.70% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 317,856 | $16,547,583 | 5.57% |
| Deep Track Capital, LP | 2,600,000 | $135,434,000 | 5.23% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,369,849 | $71,355,434 | 3.86% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,730 | $10,872,746 | 3.30% |
| DCF Advisers, LLC | 107,157 | $5,581,808 | 3.04% |
| Bellevue Group AG | 3,170,250 | $165,138,323 | 2.66% |
| Vahanian & Associates Financial Planning Inc. | 15,217 | $792,654 | 2.55% |
| Iron Triangle Partners LP | 330,549 | $17,218,297 | 2.52% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $15,627,000 | 2.20% |